[Therapeutic management of menometrorrhagia in hemostasis disorders].
Numerous epidemiological studies have confirmed an association between disorder of hemostasis and menorrhagia with an incidence of von Willebrand factor deficiency of 13%, the most common underlying bleeding disorder. In this context, a multidisciplinary approach is the best model. Similarly, women using anticoagulant treatment are exposed to menorrhagia or metrorraghia. The research of both gynaecological disease and therapeutic overdose is necessary.